Sun Pharmaceutical Industries has proposed a final dividend of ₹5 per equity share for FY2025-26. The dividend payout is subject to shareholder approval at the upcoming AGM on July 31, 2026.
Sun Pharma Proposes ₹5 Final Dividend; AGM on July 31
Sun Pharmaceutical Industries has proposed a final dividend of ₹5 per equity share for the financial year 2025-26. Shareholders can expect dividend payment by August 7, 2026, subject to approval. Reader Takeaway: A ₹5 per share dividend is proposed, with a record date of July 7, 2026. ## What just happened Sun Pharmaceutical Industries announced its plan to distribute a final dividend of ₹5 per equity share for the financial year 2025-26. This proposal awaits the approval of the company's shareholders during the 34th Annual General Meeting (AGM). ## Why this matters For investors, this means a potential return on their investment. Shareholders whose names appear on the company's register by the record date will be eligible to receive this dividend, provided it is approved at the AGM. ## The backstory Sun Pharmaceutical Industries is a global pharmaceutical company with a significant presence in India and international markets. The company typically announces dividends as part of its financial performance review and shareholder value distribution. ## What changes now Shareholders need to be aware of the key dates. The record date of July 7, 2026, is crucial for determining eligibility. The AGM on July 31, 2026, will confirm the dividend payout. If approved, the payment is expected by August 7, 2026. ## Risks to watch No specific risks were highlighted in the filing concerning this dividend proposal. However, like any dividend payout, it is contingent on shareholder approval and the company's financial health. ## Peer comparison Sun Pharma's dividend policy is generally in line with other large-cap pharmaceutical companies in India, which often distribute a portion of their profits to shareholders as dividends. ## Context metrics (time-bound) * **Proposed Final Dividend:** ₹5 per equity share. * **Record Date:** July 7, 2026. * **AGM Date:** July 31, 2026. * **Expected Payment Date:** On or before August 7, 2026. ## What to track next Investors should monitor the outcome of the AGM on July 31, 2026, to confirm the dividend approval and track the payment timeline on or before August 7, 2026.
